Richard Huxtable

Richard Huxtable (born 1974) is the Deputy Director and Professor in Medical Ethics and Law at the Centre for Ethics in Medicine, at the University of Bristol.[1][2] He is known principally for his work on legal and ethical issues in end-of-life decision-making and euthanasia, surgery and paediatrics and is the author of a number of books on these themes; Law, Ethics and Compromise at the Limits of Life: To Treat or Not to Treat? (2012), Euthanasia, Ethics and the Law: From Conflict to Compromise (2007) and (with Dickenson & Parker) The Cambridge Medical Ethics Workbook (CUP, 2nd edn, 2010). He has also produced numerous chapters, and articles for both academic journals and mainstream newspapers.

Huxtable is best known for his controversial position on the role of "principled compromise" in responding to conflict over the care of a critically ill, incapacitated patient. Huxtable has argued that the law governing both the welfare (or "best interests") of the patient and any wishes they might have conveyed, via an "advance directive" or through the appointment of a "lasting power of attorney", frequently fail to furnish clinicians and families with the guidance they require in these difficult cases. He has proposed that there is a case for "principled compromise" here, and has argued for greater ethical engagement, through a reinvigorated system of clinical ethics support, in which committees work alongside the courts to resolve the conflicts that can arise at the limits of life.[3]

Education and career

Born and educated in South Wales, Richard Huxtable studied Law at Nottingham University before completing a PhD on Assisted Dying and English Law at the University of Bristol, where he now teaches. He has held visiting positions at the Ethox Centre in the University of Oxford,[4] the Centre for Biomedical Ethics in the National University of Singapore[5] and the Hastings Center, New York.[2] A long-standing participant in clinical ethics consultation, Huxtable is a member of the UHBT Clinical Ethics Advisory Group[2] and a Trustee of both the UK Clinical Ethics Network[6] and of the National Council for Palliative Care.[7] His research has been funded by organisations including the Wellcome Trust[8] and the European Commission[9] and he has given invited presentations at the Royal Society of Medicine[10] and the Royal College of Surgeons.[11] He has given expert evidence to The Commission on Assisted Dying[12] which was run by the UK think tank Demos.[13]

Publications

Books

Contributions

Other publications

"Opinion: The Edge of Life". New Scientist. 15 January 2014. Retrieved 5 March 2014. 

References

  1. ↑ "New Appointments in SSCM". University of Bristol. Retrieved 1 August 2014.
  2. 1 2 3 "Dr Richard Huxtable". University of Bristol. Retrieved 5 March 2014.
  3. ↑ Huxtable, Richard (2012). Law, Ethics and Compromise at the Limits of Life: To Treat or Not to Treat?. London: Routledge. pp. outside back cover. ISBN 1136227024.
  4. ↑ "Visiting Researchers". Ethox Centre. Retrieved 5 March 2014.
  5. ↑ "Visiting Staff & Consultants". National University of Singapore. Retrieved 5 March 2014.
  6. ↑ "Board of Trustees". UK Clinical Ethics Network. Retrieved 5 March 2014.
  7. ↑ "Trustees". National Council for Palliative Care. Retrieved 5 March 2014.
  8. ↑ "Wellcome Trust Grants Awarded 2009/10" (PDF). Wellcome Trust. Retrieved 5 March 2014.
  9. ↑ "Professor Richard Huxtable". University of Bristol. Retrieved 13 October 2015.
  10. ↑ "Is the Principle of Double Effect Still Relevant in End of Life Care?". Royal Society of Medicine. Retrieved 12 March 2014.
  11. ↑ "Seminar Report". Royal College of Surgeons. Retrieved 12 March 2014.
  12. ↑ "Transcript of Evidence" (PDF). Commission on Assisted Dying. Retrieved 12 March 2014.
  13. ↑ "Commission on Assisted Dying". Demos. Retrieved 12 March 2014.
This article is issued from Wikipedia - version of the Sunday, October 25, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.